ARA-290 (Cibinetide) 10mg

Description

⚠️ FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION

Research Background

ARA-290 (Cibinetide) selectively activates the innate repair receptor (IRR/betacR) without haematopoietic EPO receptor binding. Used in neuroprotection and peripheral nerve biology research.

All research summaries are for informational purposes only and do not constitute medical claims. Vexar Lab compounds are not approved for human use.

Compound Data

• CAS Number: 891126-33-3
• Molecular Formula: C20H36N6O8
• Molecular Weight: 504.5 g/mol
• Sequence / Structure: 11-residue helix B surface peptide of EPO
• Appearance: White lyophilised powder
• Solubility: Water soluble

Purity & Testing

• Purity: ≥99% HPLC-UV
• Analysis: HPLC-UV
• Mass Confirmation: ESI-MS

Storage & Handling

• Sealed: −20°C away from light and moisture
• Reconstituted: 4°C use within 21 days
• Stability: 24 months

Reconstitution Guide

Reconstitute with sterile or bacteriostatic water. Store at 4°C, use within 21 days.

For research purposes only — not for human consumption.

Ordering

Minimum order £300. £45 flat worldwide shipping. Custom vial labelling available (+3 weeks lead time). Unlabelled orders dispatch within 1 week.

Legal Disclaimer

FOR RESEARCH USE ONLY. Not for human consumption. Not a medicine. Not intended to diagnose, treat, cure or prevent any disease or medical condition. By purchasing you confirm you are a qualified research professional using this compound for legitimate in-vitro laboratory research purposes only. Vexar Lab accepts no liability for misuse.